Yun Sun
Changchun, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Daphnoretin as a potent sortase A inhibitor effectively disarms drug-resistant Staphylococcus aureus infections.
Journal: World journal of microbiology & biotechnology
Published: October 09, 2025
Tetrahedral framework nucleic acid delivery of emodin enables precision antibacterial and anti-inflammatory therapy for drug-resistant Staphylococcus aureus.
Journal: Journal of nanobiotechnology
Published: October 09, 2025
Integrative virtual and empirical screening to identify multi-target flavonoid quercetin-3-O-glucuronide for reducing MRSA pathogenicity.
Journal: International journal of antimicrobial agents
Published: August 04, 2025
Puerarin as a dual inhibitor of Staphylococcus aureus coagulase and von Willebrand factor-binding protein for targeted therapy against MRSA skin infection.
Journal: Biochemical pharmacology
Published: March 28, 2025
Astragaloside IV as a potent vWbp inhibitor: An innovative strategy to mitigate foodborne Staphylococcus aureus infections.
Journal: Biochemical pharmacology
Published: December 20, 2024
Disarming the Pathogenicity of Methicillin-Resistant Staphylococcus aureus via Osmundacetone-Mediated Inhibition of Sortase A.
Journal: Microbial biotechnology
Published: October 10, 2024
Targeting ClpP: Unlocking a novel therapeutic approach of isochlorogenic acid A for methicillin-resistant Staphylococcus aureus-infected osteomyelitis.
Journal: Microbiological research
Published: October 04, 2024
Baohuoside I targets SaeR as an antivirulence strategy to disrupt MRSA biofilm formation and pathogenicity.
Journal: NPJ biofilms and microbiomes
Published: September 29, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026